2013•The Practical Journal of CancerRequires access

The Study of Inhibitory Effect of VPA Combined with Paclitaxel on Cervical Cancer Hela Cells

LU Bing-yin

Open publisher page 0 citations

Abstract

Objective To explore the inhibitory effect of histone deacetylase inhibitor VPA combined with paclitaxel on human cervical cancer Hela cells.Methods Hela cells were treated with VPA and paclitaxel alone and in combination.The cell condition was observed by microscope.Cell proliferation was studied by MTT assay.The apoptosis and cell cycle were determined by flow cytometry.Results The Hela cells were significantly inhibited by VPA in a time and dose-dependent manner,and VPA induced enhanced apoptosis and G2/M phase arrest.When combined with paclitaxel,VPA induced more severe apoptosis and arrested much more cells at G2/M phase;meanwhile the cells of S phase were decreased.Conclusion VPA can significantly inhibit the proliferation of Hela cells and induce apoptosis,enhancing paclitaxel's killing effect on Hela cells.

About this research paper

What this paper is about

Objective To explore the inhibitory effect of histone deacetylase inhibitor VPA combined with paclitaxel on human cervical cancer Hela cells.Methods Hela cells were treated with VPA and paclitaxel alone and in combination.The cell condition was observed by microscope.Cell proliferation was studied by MTT assay.The apoptosis and cell cycle were determined by flow cytometry.Results The Hela cells were significantly inhibited by VPA in a time and dose-dependent manner,and VPA induced enhanced apoptosis and G2/M phase arrest.When combined with paclitaxel,VPA induced more severe apoptosis and arrested much more cells at G2/M phase;meanwhile the cells of S phase were decreased.Conclusion VPA can significantly inhibit the proliferation of Hela cells and induce apoptosis,enhancing paclitaxel's killing effect on Hela cells.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the inhibitory effect of histone deacetylase inhibitor VPA combined with paclitaxel on human cervical cancer Hela cells.Methods Hela cells were treated with VPA and paclitaxel alone and in combination.The cell condition was observed by microscope.Cell proliferation was studied by MTT assay.The apoptosis and cell cycle were determined by flow cytometry.Results The Hela cells were significantly inhibited by VPA in a time and dose-dependent manner,and VPA induced enhanced apoptosis and G2/M phase arrest.When combined with paclitaxel,VPA induced more severe apoptosis and arrested much more cells at G2/M phase;meanwhile the cells of S phase were decreased.Conclusion VPA can significantly inhibit the proliferation of Hela cells and induce apoptosis,enhancing paclitaxel's killing effect on Hela cells.

Key concepts: HeLa, Apoptosis, Paclitaxel, MTT assay, Cell cycle, Flow cytometry, Chemistry, Cell growth

Related papers

Back to paper searchBrowse research topicsOriginal source
The Study of Inhibitory Effect of VPA Combined with Paclitaxel on Cervical Cancer Hela Cells — Research Paper | ScholarLens